Bharat Parenterals
add_icon

Bharat Parenterals

1,047.00
+2.00
(0.19%)
Market Cap
721.58 Cr
PE Ratio
-25.20
Volume
204.00
Day High - Low
1,087.95 - 966.80
52W High-Low
1,667.20 - 880.25
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
721.58 Cr
EPS
-66.64
PE Ratio
-25.20
PB Ratio
2.18
Book Value
480.27
EBITDA
14.30
Dividend Yield
0.10 %
Industry
Healthcare
Return on Equity
-12.88
Debt to Equity
0.64
Forecast For
Actual

Company News

View All News
Caret
neutral
Bharat Parenterals reported Q3FY26 standalone revenue of ₹41.41 crore, down 38.5% YoY, with net profit at ₹1.95 crore. Company maintains order book of ₹303 crore for future execution.
positive
Bharat Parenterals Limited announced the appointment of Mr. Keval Sanjaykumar Shah as Vice President - Operations effective January 01, 2026, bringing over 10 years of experience in supply chain and operations management.
positive
Bharat Parenterals' Subsidiary Innoxel Lifesciences Clears EU GMP Inspection with Zero Critical ObservationsNov 28, 2025
Innoxel Lifesciences, a subsidiary of Bharat Parenterals Limited, successfully completed European Union Good Manufacturing Practice inspection by Belgium's FAMHP from November 24-28, 2025, with zero critical and zero major observations. The milestone strengthens the company's regulatory credentials for international markets and supports its strategic growth objectives following earlier successful USFDA inspection outcomes.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,693.60
#1 4,06,351.37
37.86
#1 54,729.00
9.71
#1 10,980
16.07
37.98
5,856.50
1,55,471.67
63.26
9,712.00
18.67
2,191
-1.02
33.24
3,987.20
1,34,944.97
61.20
11,539.40
6.99
1,911
26.24
32.75
2,274.50
1,03,954.48
22.26
22,909.50
13.74
3,306
#1 37.44
47.35
1,217.30
1,01,601.09
18.27
33,741.20
16.73
5,725
-15.28
39.36
1,192.40
96,319.77
21.31
28,409.50
7.12
5,291
-57.18
26.86
864.25
86,963.77
#1 17.29
23,511.00
18.55
4,615
-0.32
41.42
1,998.50
82,499.09
45.81
12,744.20
#1 20.90
2,007
7.65
41.40
1,333.70
77,461.51
22.37
32,345.60
9.43
3,484
7.59
64.38
5,258.00
62,867.28
25.87
13,458.30
3.70
2,216
1.90
42.54
Growth Rate
Revenue Growth
32.38 %
Net Income Growth
-516.19 %
Cash Flow Change
-478.56 %
ROE
-392.06 %
ROCE
-167.54 %
EBITDA Margin (Avg.)
-65.91 %

Quarterly Financial Results

Quarterly Financials
Dec 2016
Sept 2017
Dec 2017
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
27
37
32
40
52
94
46
53
53
77
57
57
62
52
42
63
63
40
55
28
88
63
51
72
62
61
71
95
76
75
106
117
68
67
Expenses
26
32
28
32
39
82
38
44
45
63
48
47
51
44
38
50
50
36
48
24
73
56
45
60
56
53
67
88
79
69
102
102
64
64
EBITDA
2
5
4
9
13
12
8
9
8
14
9
11
11
8
4
12
13
4
7
3
16
6
7
13
7
8
4
7
-4
7
4
15
4
3
Operating Profit %
6 %
13 %
13 %
15 %
23 %
9 %
10 %
11 %
9 %
15 %
13 %
15 %
14 %
11 %
6 %
17 %
17 %
7 %
8 %
7 %
11 %
4 %
12 %
15 %
7 %
11 %
1 %
5 %
-11 %
5 %
2 %
12 %
1 %
3 %
Depreciation
1
2
1
1
2
2
2
2
2
2
1
1
1
2
2
2
2
2
2
2
2
1
1
2
2
2
4
9
9
9
9
9
9
9
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
3
3
3
4
4
3
3
Profit Before Tax
2
3
4
7
11
11
6
7
6
12
7
9
9
6
2
10
11
2
5
2
14
4
4
10
5
6
-1
-5
-15
-6
-8
3
-7
-8
Tax
0
1
1
2
7
4
1
2
2
4
0
3
3
1
1
3
3
1
1
0
4
1
2
3
2
2
1
4
2
2
1
3
1
1
Net Profit
2
3
3
5
4
7
5
5
4
8
7
7
6
5
2
8
8
1
4
1
10
3
2
7
2
4
-3
-9
-18
-8
-9
-1
-9
-10
EPS in ₹
2.94
4.62
5.45
9.15
7.46
11.34
9.13
8.29
7.29
14.11
12.45
11.58
11.26
9.46
3.29
13.49
13.88
2.32
7.04
2.03
17.19
4.94
4.24
13.03
6.07
6.45
-0.62
-2.11
-27.00
-11.42
-14.40
-1.00
-12.48
-14.03

Balance Sheet

Balance Sheet
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
120
111
132
159
188
199
226
350
504
649
Fixed Assets
35
31
34
35
33
45
41
42
211
252
Current Assets
72
64
91
118
132
148
144
184
262
356
Capital Work in Progress
0
0
0
1
12
0
26
99
25
31
Investments
0
1
1
2
0
43
12
0
0
5
Other Assets
86
79
98
121
142
111
148
209
269
360
Total Equity & Liabilities
120
111
132
159
188
199
226
350
504
649
Current Liabilities
56
43
57
61
66
44
42
120
190
219
Non Current Liabilities
7
4
2
4
3
11
14
13
76
90
Total Equity
57
64
73
94
118
144
170
218
238
339
Reserve & Surplus
51
58
67
88
113
138
160
177
191
324
Share Capital
6
6
6
6
6
6
6
6
6
7

Cash Flow

Cash Flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
-11
2
7
-1
-8
2
4
1
-8
Investing Activities
0
-2
-8
-9
-13
-43
-7
-78
-105
-137
Operating Activities
0
-2
6
20
14
25
-1
22
-5
-27
Financing Activities
0
-8
4
-4
-3
11
9
61
110
156

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Oct 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
74.42 %
74.42 %
74.42 %
74.42 %
73.84 %
73.84 %
73.84 %
73.84 %
73.84 %
73.84 %
73.84 %
73.84 %
73.26 %
73.27 %
65.35 %
67.20 %
67.20 %
67.20 %
67.19 %
67.19 %
67.19 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.08 %
0.08 %
0.11 %
0.11 %
0.11 %
0.11 %
0.11 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.57 %
0.54 %
0.54 %
0.54 %
0.54 %
0.54 %
0.54 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.56 %
16.38 %
16.23 %
15.46 %
15.55 %
15.65 %
14.85 %
14.70 %
13.31 %
13.21 %
13.00 %
12.99 %
13.61 %
13.60 %
20.07 %
19.00 %
19.20 %
18.94 %
19.31 %
19.27 %
19.21 %
Others
9.01 %
9.19 %
9.34 %
10.11 %
10.60 %
10.50 %
11.30 %
11.45 %
12.84 %
12.95 %
13.15 %
13.16 %
13.11 %
13.13 %
13.92 %
13.18 %
12.95 %
13.21 %
12.85 %
12.89 %
12.94 %
No of Share Holders
0
2,572
3,122
2,912
2,805
2,796
2,765
2,700
2,515
2,485
2,481
2,397
2,497
2,727
2,748
2,750
3,116
3,177
3,231
3,205
3,172

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.75 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.1 0.11 0.00

Announcements

Closure of Trading WindowMar 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 30, 2026
Financial Results For The Quarter And Nine Months Ended On December 31 2025.Jan 30, 2026
Board Meeting Outcome for Outcome Of Board Meeting For The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On December 31 2025.Jan 30, 2026
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Month Ended On December 31 2025.Jan 22, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 13, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 06, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJan 01, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 10, 2025
Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window.Dec 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2025
Report On Transfer Requests Of Physical Shares Re-Lodged Under The Special Window.Nov 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 12, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Nov 12, 2025
For The Quarter And Half Year Ended September 30 2025Nov 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 12, 2025
Board Meeting Outcome for For Unaudited Financial Results For The Quarter And Half Year Ended On September 30 2025.Nov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 07, 2025
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On September 30 2025.Nov 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Closure of Trading WindowSep 26, 2025
Closure of Trading WindowSep 26, 2025
Shareholder Meeting / Postal Ballot-Outcome Of AGM.Sep 26, 2025
Intimation Of The Record Date For The Purpose Of The Dividend For FY 2024-25.Sep 10, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Intimation Under Regulation 36 Of The SEBI (LODR) Regulations 2015.Sep 04, 2025
Intimation Of Record DateSep 04, 2025
Intimation Of Book ClosureSep 04, 2025
Reg. 34 (1) Annual Report.Sep 04, 2025
Notice Of The 32Nd Annual General Meeting Of Bharat Parenterals Limited To Be Held On Friday September 26 2025.Sep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 01, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 28, 2025
Appointment Of Statutory Auditors Of The Company & Its Material Subsidiaries.Jul 28, 2025
Re-Appointment Of Mr. Mukesh Patel As A Non-Executive Independent Director Of The CompanyJul 28, 2025

Technical Indicators

RSI(14)
Neutral
52.03
ATR(14)
Volatile
90.27
STOCH(9,6)
Neutral
36.66
STOCH RSI(14)
Neutral
62.72
MACD(12,26)
Bullish
0.03
ADX(14)
Weak Trend
19.98
UO(9)
Bearish
36.72
ROC(12)
Downtrend And Accelerating
-3.73
WillR(14)
Neutral
-32.42